Skip to Main Content

Contribute Try STAT+ Today

Hillary Clinton

Most Read

Pharma By Ed Silverman

Pharmalittle: Did Hal Barron hit his goals before leaving Glaxo? FDA rejects drugs from Merck and Pfizer

Stock exchange

Biotech By Adam Feuerstein, Meg Tirrell and Damian Garde

Biotech stocks are a dumpster fire. An analyst explains what’s going on

First Opinion By Yonatan Adiri

Antigen testing has some serious problems. Done right, it could reshape the future of health care

grief hardship clinicians

First Opinion By Krista Lyn Harrison, Meridith Greene and Anthony Galanos

We all need help working through grief and hardship

Hal Barron

Biotech By Matthew Herper

Did veteran drug developer Hal Barron accomplish his mission at GSK?

Health Tech By Casey Ross

‘We must change’: Health systems invest more aggressively than ever in digital health

Clinical Trials illo

Pharma By Matthew Herper

They built a smarter approach to Covid clinical trials. Now they want to do the same for other diseases

Diphtheria Vaccine

First Opinion By Christopher Hartnick

Using force crossed my mind when examining a defiant young patient. A short story made me take a breath

All Coverage

Pharmalot By Ed Silverman

Clinton campaign questioned FDA commissioner’s ties to pharma

Donald Trump, Hillary Clinton

Politics By Damian Garde

Whether it’s Trump or Clinton, biotech is in for ‘a moment of change’

advertisement

Dr. Mehmet Oz

First Opinion By Vishal Khetpal

Do ethics fall to the wayside when doctors become pundits?

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Novo Nordisk cutting 1,000 jobs amid diabetes drug price war

Donald Trump & Hillary Clinton

First Opinion By Larry Tye

‘Mr. Trump, are you out of your mind?’ Health policy questions I’d ask at the debate

Clinton and Trump

Politics By Associated Press

Study: Contrasting outcomes from candidates’ health plans

Trump & Clinton

Politics By Sharon Begley

5 takeaways from this week’s Clinton-Trump medical circus

Pharmalot By Ed Silverman

Bipartisan bill in Congress would require drug makers to justify, limit price hikes

Donald Trump

Politics By Dylan Scott

Donald Trump’s health is ‘excellent,’ doctor says in releasing test results

Anesthesiologist

First Opinion By Catherine M. Mullaly

If my health as an anesthesiologist has to be painstakingly vetted, so should a president’s

Clinton doctor

Politics By Sheila Kaplan

Hillary Clinton’s doctor remains out of the spotlight as attention to candidate health escalates

Hillary clinton

Politics By Dylan Scott

Hillary Clinton remains ‘healthy and fit to serve,’ her doctor says in new letter

Clinton and Trump

Politics By Andrew Joseph and Rebecca Robbins

An experts guide: How to evaluate health disclosures from Donald Trump and Hillary Clinton

Mitt Romney & Garrett Jackson

Politics By Dylan Scott

Want to keep healthy on the campaign trail? Good luck, say political veterans

Hillary Clinton health

Politics By Dylan Scott

Hillary Clinton to release additional health records, campaign says

Health By Helen Branswell

Hillary Clinton has pneumonia. What does that mean? We’ve got answers

Politics By Lisa Raffensperger and Dylan Scott

Clinton’s ‘overheating’ episode was related to pneumonia treatment, her physician says

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: FDA fast tracks Biogen drug for Alzheimer’s

Hillary Clinton

Politics By Dylan Scott

Clinton seeks federal panel to determine if drug price hikes are justified

Nixon Health

Politics By Dylan Scott

A history of health rumors running rampant in presidential campaigns

Politics By Associated Press

Hillary Clinton rolling out comprehensive mental health plan

Politics By Dylan Scott

Smears over a candidate’s personal health can work. Just ask Michael Dukakis

Pharmalot By Ed Silverman

Under fire, Mylan takes steps to make $600 EpiPen more affordable

Hillary Clinton Zika

Politics By Associated Press

Hillary Clinton proposes new federal fund to combat Zika

Politics By Dylan Scott

Hillary Clinton’s health care agenda is in danger as Obamacare struggles